CopyMark Law Group
4.9/5
Drawing for CANCERLINQ DISCOVERY

USPTO serial 87290547

CANCERLINQ DISCOVERY

Reviewed by CopyMark Law Group

Reg. 5376694Status 702Renewal
Filing date
Status date
Registration date
Jan 9, 2018
Examiner
KOLODNER, LOUIS FRANCIS
Law office
TMO LAW OFFICE 122

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CANCERLINQ DISCOVERY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,300

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher A. Proskey

Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVE, SUITE 2000DES MOINES, IA 50309United States

Goods and services

ClassDescriptionStatusFirst use
042Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; application service provider featuring software for use in aggregating and analyzing health care and medical data; Scientific and medical research, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare data and preparing reports in connection therewithACTIVEOct 2, 2017
044Providing physicians and other healthcare providers information in the field of neoplastic disease prevention, screening, diagnosis and treatment; providing patient information in the field of neoplastic diseasesACTIVEOct 2, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 7, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 7, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 14, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 14, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 13, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 31, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 9, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Jan 9, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 9, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 6, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 5, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 2, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 1, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 16, 2017IUAFUSE AMENDMENT FILED—
Nov 16, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 16, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 8, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 8, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 8, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 31, 2017DOCKASSIGNED TO EXAMINER—
Jan 14, 2017MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jan 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance